New brain implant shows promise against deadly recurrent cancer
NCT ID NCT07349693
Summary
This study is testing whether adding a new implant called Cerebraca Wafer to standard chemotherapy helps people with recurrent glioblastoma, a serious brain cancer, live longer. The trial will compare two groups: one receiving the wafer implant plus chemotherapy after surgery, and another receiving only chemotherapy. Researchers aim to enroll 175 adults whose cancer has returned after initial treatment, to see if the combination approach improves survival and delays cancer progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA IDH WILDTYPE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Legorreta Cancer Center Warren Alpert Medical School of Brown University
Providence, Rhode Island, 02903, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.